Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Endpoints news

LGBTQ+ Biopharma Leaders

Endpoints News featured Jason Mellad, CEO and Co-Founder of Start Codon in their recent report.

Endpoints News has published its annual LGBTQ+ Biopharma Leaders report featuring Start Codon's very own Jason Mellad, CEO and Co-founder.

Within the report, Jason discusses how the biopharma industry must address the needs of the LGBTQ+ community.

Jason said: "It's not just increasing diversity in key positions; they should have the best interest of the broader community at heart."

In conjunction with the LGBTQ+ report, Jason joined a panel and Q&A to provide insights as an LGBTQ+ leader in the biopharma industry.